International ethical guidelines for biomedical research involving human subjects.
Council for International Organizations of Medical Sciences
https://pubmed.ncbi.nlm.nih.gov/14983848/Actively Recruiting
Led by The Mentor Initiative · Updated on 2026-07-29
5556
Participants Needed
1
Research Sites
7 weeks
Total Duration
Researchers are evaluating the effectiveness of using a larvicide called Dimilinae and baited fly traps named iCatchiae ProMax to reduce filth fly populations and decrease the spread of diarrhoeal diseases in refugee camps located in Maban County, South Sudan. The study is a phase 3 interventional trial with a non-randomized crossover design conducted in four refugee camps housing over 218,000 people. The study aims to see if these interventions reduce diarrhoea cases and fly densities at latrines and shelters. The trial involves three intervention phases, each lasting six months, separated by one-month washout periods. In the first intervention, Dimilinae granules will be applied monthly to eligible pit latrines to interrupt fly development. The second intervention uses iCatchiae ProMax fly traps placed outdoors near latrines and re-baited every eight weeks. The third phase combines both interventions. The control group receives no intervention. Project staff will oversee intervention placement and removal throughout the study. Participants, including individuals aged 1 year and older living in the camps, will be recruited into two cohorts under 5 years and 15 years or older and monitored every two weeks during each implementation phase for diarrhoeal incidence using surveys and local health facility data. Entomological monitoring of fly densities and species will also be conducted regularly. Laboratory analyses will assess fly samples for pathogen presence and resistance. Data collection involves GPS mapping, questionnaires, and biological assays, with results analyzed to measure the impact of the interventions on diarrhoea and fly populations over the study period.
CONDITIONS
Reducing Filth Fly Populations and Transmission of Diarrhoeal Pathogens in Harsh Settings
R
Richard James Allan, PhD
L
Louisa Alexandra Messenger, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
The Mentor Initiative
Lead Sponsor
University of Nevada, Las Vegas
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 6 months
Participants in certain camps receive either larvicide treatment or fly traps while control camps receive no intervention. Interventions are applied and monitored for 6 months.
Fortnightly surveys and monitoring visits
Duration - 1 month
Interventions are removed or allowed to dissipate during this 1-month break between implementation phases.
Duration - 6 months
Participants in camps switch interventions, with larvicide and fly trap assignments swapped. Monitoring continues for another 6 months.
Fortnightly surveys and monitoring visits
Duration - 1 month
Interventions are removed or allowed to dissipate during this 1-month break between implementation phases.
Duration - 6 months
Participants in camps receive both larvicide treatment and fly traps combined. Monitoring continues for 6 months.
Fortnightly surveys and monitoring visits
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
NON_RANDOMIZED
Model
CROSSOVER
Primary Purpose
PREVENTION
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Council for International Organizations of Medical Sciences
https://pubmed.ncbi.nlm.nih.gov/14983848/D Cohen, M Green, C Block...
https://pubmed.ncbi.nlm.nih.gov/1673210/Drew Capone, Zaida Adriano, Oliver Cumming...
https://pubmed.ncbi.nlm.nih.gov/36516327/Mark S Riddle, Gregory J Martin, Clinton K Murray...
https://pubmed.ncbi.nlm.nih.gov/28885922/W A Nazni, H Luke, W M Wan Rozita...
https://pubmed.ncbi.nlm.nih.gov/16880754/Drew Capone, Oliver Cumming, Abeoseh Flemister...
https://pubmed.ncbi.nlm.nih.gov/38507457/Elisabeth Mahase
https://pubmed.ncbi.nlm.nih.gov/38548295/Francis Chinedu Onwugamba, Alexander Mellmann, Victor Oluoha Nwaugo...
https://pubmed.ncbi.nlm.nih.gov/33046808/GBD 2021 Diarrhoeal Diseases Collaborators
https://pubmed.ncbi.nlm.nih.gov/39708822/Richard J Allan, Mohammad Kamal, Sajjad Ahmad...
https://pubmed.ncbi.nlm.nih.gov/42015057/The Mentor Initiative
Lead Sponsor
University of Nevada, Las Vegas
Collaborating Sponsor